The Drug Enforcement Agency (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) jointly issued a second temporary rule that extends the full set of COVID-19 telemedicine flexibilities for prescription of controlled medications through December 31, 2024. What is it. The agencies note that as the DEA and the Department of Health and Human Services (HHS) continue to… (Slifer, October 6, 2023) #Mental and Behavioral Health, #Prescription Drugs, #Telehealth